For over 20 years, we have focused on the design, development, manufacture, and sale of patented laser technologies. Our superpulsed, dual-wavelength lasers are safe and effective, allowing your patients to start Healing at the Speed of Light®
Revolutionize your practice with Smart Laser Technology - Social Event
Join us for an evening of celebration on community and partnerships starting at Nov 1 Fri 6pm. Complimentary Drinks & Hors d’oeuvres are served. RSVP Today.
Get a TLC-1000 with a 35% discount this summer!
Don't miss your chance to get Theralase TLC-1000 cold laser therapeutic system at the lowest price of the year. Click to learn more.
Receive up to $700 when you refer a healthcare practitioner who is interested in purchasing a Cold Laser System.
Free Educational Webinars
Theralase® webinars are an excellent resource for the busy clinician who wants to learn more about laser therapy and the evidence behind its use but does not have a lot of free time.
Educational Seminars - September 2019
Theralase® seminars are designed to empower clinicians with the requisite knowledge for evidence-based practice. Click to see available locations.
Healing at the Speed of Light®
We also design, manufacture and distribute patented and proprietary super-pulsed cool laser technology for the treatment of knee pain, and in off-label use, the treatment of numerous nerve, muscle and joint conditions.
We are a Canadian clinical stage pharmaceutical company dedicated to the research and development of light-activated Photo Dynamic Compounds and their associated drug formulations to safely and effectively destroy cancer.
Super-Pulsed Cool Laser Technology
With up to 4 probes, the versatile TLC-2000 series helps you treat multiple conditions at the same time, or multiple patients simultaneously, enhancing productivity, growing revenue, and driving patient satisfaction.
Completed Phase 1b Clinical Study
Our laser systems have been used to treat over 1,000,000 patients worldwide, and our anti-cancer technology has now successfully completed a Phase 1b Clinical Study for Non-Muscle Invasive Bladder Cancer ("NMIBC").
Theralase® Technologies Inc. is a biopharmaceutical company headquartered in Toronto, Canada focused on the design, development, manufacturing, and sale of patented laser technology platforms used in a wide range of bio-stimulative and bio-destructive clinical applications in patients.
Founded in 1994, Theralase’s operations are divided into two divisions: the production of therapeutic laser technology for commercial applications, and the research and development of laser-based technologies for the destruction of cancer cells and other disease states.
Therapeutic Laser Technology Division
Theralase® focuses on the development of laser-based of laser-based non-invasive therapeutic devices to eliminate pain, reduce inflammation, and accelerate tissue healing.
Theralase® develops advanced pharmaceutical products and medical devices based on proprietary non-immunosuppressive photodynamic technology, targeting high anti-cancer effectiveness, microbial sterilization potency, and bacterial infection control.